Certolizumab seems effective as monotherapy in RA patients with failure to csDMARDsNovember 30, 2021Rheumatoid Arthritis
Baricitinib demonstrates consistent long-term safety profile in RANovember 30, 2021Rheumatoid Arthritis
RA: bDMARD monotherapy may accelerate radiographic progression of preexisting distal hand osteoarthritisNovember 30, 2021Rheumatoid Arthritis
No risk of increased flare after 2 doses of COVID-19 vaccination in RANovember 30, 2021Rheumatoid Arthritis
Rheumatology NewsLow-dose rituximab may keep RA disease activity low in respondersNovember 19, 2021Rheumatoid Arthritis
Rheumatology NewsLong-term glucocorticoids in RA linked to increased cardiovascular riskNovember 17, 2021Rheumatoid Arthritis
Rheumatology NewsTofacitinib postmarketing trial data shed light on JAK inhibitor risksNovember 16, 2021Rheumatoid ArthritisPsoriatic Arthritis
Rheumatology NewsmRNA COVID vaccine response found mostly robust in RA, SLE patientsNovember 11, 2021COVID-19 UpdatesRheumatoid ArthritisLupus & Connective Tissue Diseases
Rheumatology NewsWhen a JAK inhibitor fails for a patient with RA, what’s next?November 10, 2021Rheumatoid Arthritis
Rheumatology NewsStatins’ effects on CVD outweigh risk for diabetes in RANovember 9, 2021Rheumatoid Arthritis
Rheumatology NewsAbatacept shows signal to delay onset of rheumatoid arthritisNovember 8, 2021Rheumatoid Arthritis
Rheumatology NewsRisk for VTE in RA may be higher with MTX vs. hydroxychloroquineNovember 2, 2021Rheumatoid Arthritis
Progressive muscle relaxation enhances sleep quality and decreases fatigue in RAOctober 24, 2021Rheumatoid Arthritis
